EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Extended passaging of the SKOV3 ovarian cancer cell line leads to two phenotypically different strains

Eglė Žymantaitė iD, Migle Gabrielaite iD, Vita Pašukonienė iD, Agata Mlynska iD

Disease Models & Mechanisms · 2025

DOI: 10.1242/dmm.052451 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Disease Models & Mechanisms, 2025. Verfasst von Eglė Žymantaitė und 3 weiteren Autor:innen. Beteiligte Einrichtung: Laboratory of Immunology, National Cancer Institute, P. Baublio g. 3B, LT-08406 Vilnius, Lithuania. Hauptthemen laut MEDLINE: Ovarian Neoplasms. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 44 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Vilnius University, Science Promotion Fund for Scientific Projects, 2024-2025, HORIZON-MSCA-2023-PF-01, Vilnius University.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Continuous passaging of cancer cell lines can drive phenotypic and genotypic divergence, potentially compromising the reliability of such models. In this study, we show that two late-passage strains (S1 and S2) of ovarian cancer cell line SKOV3, although authenticated via short tandem repeat (STR) profiling as identical, exhibit substantial differences in morphology, transcriptomic signatures, ability to form 3D cultures and chemotherapeutic responses. Notably, S1 formed compact 3D spheroids and exhibited enhanced epithelial-mesenchymal transition (EMT) pathway activity, whereas S2 displayed a more proliferative, MYC-driven phenotype with larger spheroid structures requiring higher seeding densities. Transcriptomic analysis revealed pathways associated with hypoxia, EMT and angiogenesis in 3D culture, highlighting the complexity introduced by dimensionality in tumour modelling. Critically, S1 showed higher sensitivity to doxorubicin than S2 (IC50 of 0.12 µM versus 1.28 µM, P=0.0001), indicating how clonal evolution can confound drug-response assays. Ultimately, our findings suggest that although STR profiling remains essential for cell line authentication, functionally distinct subpopulations can arise and coexist within the same culture, and their isolation may reveal divergent phenotypes that compromise reproducibility in preclinical cancer research.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Ovarian NeoplasmsHumansFemaleCell Line, TumorPhenotypeSpheroids, CellularEpithelial-Mesenchymal TransitionCell ProliferationGene Expression Regulation, NeoplasticDoxorubicinGene Expression Profiling

Stichwörter der Autor:innen

Cancer cell linesClonal evolutionLate passagingOvarian cancerSKOV3

Substanzen

Doxorubicin

Autor:innen und Institutionen

  • Laboratory of Immunology, National Cancer Institute, P. Baublio g. 3B, LT-08406 Vilnius, Lithuania.
  • Institute of Biosciences, Life Sciences Center, Vilnius University, Sauletekio 7, LT-10257 Vilnius, Lithuania.
  • Institute of Biotechnology, Life Sciences Center, Vilnius University, Sauletekio 7, LT-10257 Vilnius, Lithuania.
  • Department of Chemistry and Bioengineering, Vilnius Gediminas Technical University, Sauletekio al. 11, LT-10223 Vilnius, Lithuania.

ORCID-Profile: Eglė Žymantaitė, Migle Gabrielaite, Vita Pašukonienė, Agata Mlynska

Förderung

  • Vilnius University, Science Promotion Fund for Scientific Projects, 2024-2025
  • HORIZON-MSCA-2023-PF-01
  • Vilnius University
  • European Commission

Zitieren

APA

Žymantaitė, E., Gabrielaite, M., Pašukonienė, V., & Mlynska, A. (2025). Extended passaging of the SKOV3 ovarian cancer cell line leads to two phenotypically different strains. Disease Models & Mechanisms. https://doi.org/10.1242/dmm.052451

Vancouver

Žymantaitė E, Gabrielaite M, Pašukonienė V, Mlynska A. Extended passaging of the SKOV3 ovarian cancer cell line leads to two phenotypically different strains. Disease Models & Mechanisms. 2025. doi:10.1242/dmm.052451

BibTeX
@article{ymantait2025,
  author = {Žymantaitė, Eglė and Gabrielaite, Migle and Pašukonienė, Vita and Mlynska, Agata},
  title = {Extended passaging of the SKOV3 ovarian cancer cell line leads to two phenotypically different strains},
  journal = {Disease Models & Mechanisms},
  year = {2025},
  doi = {10.1242/dmm.052451}
}
Kostenlos starten →